These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21139098)

  • 1. Targeted epigenetic therapies: the next frontier?
    Tuma RS
    J Natl Cancer Inst; 2010 Dec; 102(24):1824-5. PubMed ID: 21139098
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting EZH2 and PRC2 dependence as novel anticancer therapy.
    Xu B; Konze KD; Jin J; Wang GG
    Exp Hematol; 2015 Aug; 43(8):698-712. PubMed ID: 26027790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Potential Epigenetic Therapy for NSCLC.
    Cancer Discov; 2015 Apr; 5(4):341. PubMed ID: 25724377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma.
    Papp G; Changchien YC; Péterfia B; Pecsenka L; Krausz T; Stricker TP; Khoor A; Donner L; Sápi Z
    Mod Pathol; 2013 Mar; 26(3):393-403. PubMed ID: 23174932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous and Rare: Toward Histology-Specific Treatment of Soft-Tissue Sarcoma.
    Azvolinsky A
    J Natl Cancer Inst; 2016 Jun; 108(6):djw161. PubMed ID: 27257028
    [No Abstract]   [Full Text] [Related]  

  • 6. Epigenetic Therapy in a Rare Ovarian Cancer - A Double-Edged Sword.
    Hsu C; Konner JA; Gounder MM
    N Engl J Med; 2024 Aug; 391(8):770-772. PubMed ID: 39167815
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent progress in the discovery of epigenetic inhibitors for the treatment of cancer.
    Verma SK
    Methods Mol Biol; 2015; 1238():677-88. PubMed ID: 25421686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental biology: two paths to silence merge.
    Taghavi P; van Lohuizen M
    Nature; 2006 Feb; 439(7078):794-5. PubMed ID: 16482140
    [No Abstract]   [Full Text] [Related]  

  • 9. Epigenetic therapies move into new territory, but how exactly do they work?
    Tuma RS
    J Natl Cancer Inst; 2009 Oct; 101(19):1300-1. PubMed ID: 19755677
    [No Abstract]   [Full Text] [Related]  

  • 10. Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2.
    Tsang DP; Cheng AS
    J Gastroenterol Hepatol; 2011 Jan; 26(1):19-27. PubMed ID: 21175789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic aberrations in myeloid malignancies (Review).
    Takahashi S
    Int J Mol Med; 2013 Sep; 32(3):532-8. PubMed ID: 23760684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Polycomb group protein EZH2 directly controls DNA methylation.
    Viré E; Brenner C; Deplus R; Blanchon L; Fraga M; Didelot C; Morey L; Van Eynde A; Bernard D; Vanderwinden JM; Bollen M; Esteller M; Di Croce L; de Launoit Y; Fuks F
    Nature; 2006 Feb; 439(7078):871-4. PubMed ID: 16357870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The origin of ovarian cancer—is it getting clearer?
    Birrer MJ
    N Engl J Med; 2010 Oct; 363(16):1574-5. PubMed ID: 20942676
    [No Abstract]   [Full Text] [Related]  

  • 14. Absence of mutations of the histone methyltransferase gene EZH2 in splenic b-cell marginal zone lymphoma.
    Salido M; Martinez-Avilés L; Ademà V; Ferrer A; Espinet B; Garcia M; Salar A; Besses C; Florensa L; Serrano S; Bellosillo B; Solé F
    Leuk Res; 2011 Mar; 35(3):e23-4. PubMed ID: 21087793
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeting the epigenome in ovarian cancer.
    Murphy SK
    Future Oncol; 2012 Feb; 8(2):151-64. PubMed ID: 22335580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
    Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
    Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor microRNA-101 becomes an epigenetic player by targeting the polycomb group protein EZH2 in cancer.
    Friedman JM; Jones PA; Liang G
    Cell Cycle; 2009 Aug; 8(15):2313-4. PubMed ID: 19625769
    [No Abstract]   [Full Text] [Related]  

  • 18. Precision medicine for ovarian clear cell carcinoma based on gene alterations.
    Kuroda T; Kohno T
    Int J Clin Oncol; 2020 Mar; 25(3):419-424. PubMed ID: 32020380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal presentation of a metastasizing rhabdoid tumor with homozygous deletion of the SMARCB1 gene.
    Negahban S; Nagel I; Soleimanpour H; Aledavood A; Bagheri N; Paydar M; Daneshbod K; Hasselblatt M; Gesk S; Siebert R; Daneshbod Y
    J Clin Oncol; 2010 Nov; 28(33):e688-91. PubMed ID: 20805448
    [No Abstract]   [Full Text] [Related]  

  • 20. Roles of the EZH2 histone methyltransferase in cancer epigenetics.
    Simon JA; Lange CA
    Mutat Res; 2008 Dec; 647(1-2):21-9. PubMed ID: 18723033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.